Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Friday, July 19, 2024 | Back issues
Courthouse News Service Courthouse News Service

Drug Risks

The Ninth Circuit affirmed the dismissal of negligence claims against the makers of the antidepressant drug Lexapro, finding that the drug’s packaging contained clear warning labels about a heightened risk of suicide for adolescents. 

SAN FRANCISCO – The Ninth Circuit affirmed the dismissal of negligence claims against the makers of the antidepressant drug Lexapro, finding that the drug’s packaging contained clear warning labels about a heightened risk of suicide for adolescents. 

Categories / Appeals, Business, Health

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...